Medicinal Product Shortages – update – 1 June 2022

Notice type: Advisory

Date: 01/06/2022


Further Information:

 The Health Products Regulatory Authority has been notified of a shortage of the following products:

  • Anapen Junior 150mcg in 0.3ml Solution for Injection in a Pre Filled Syringe - PA22580/001/001
  • Androcur 100mg Tablets - PA1410/001/001
  • Caelyx 2mg/ml Concentrate for Solution for Infusion (10ml presentation) - EU/1/96/011/001-002
  • Cholestagel 625mg Film Coated Tablets - EU/1/03/268/001-3
  • Doxatan XL 4mg Prolonged Release Tablets - PA0126/202/004
  • Efient 5mg Tablets - EU/1/08/503/002
  • Emtricitabine/Tenofovir disoproxil Accordpharma 200mg/245mg Film Coated Tablets - PA2315/200/002
  • Klacid LA 500mg Modified Release Tablets - PA2010/004/004
  • Palladone SR 8mg Prolonged Release Capsules - PA1688/007/009
  • Roactemra 162mg Solution for Injection in Pre Filled Pen - EU/1/08/492/009


The following shortages have been resolved and supply has resumed to the Irish market:

  • Ceftriaxone 1g Powder for Solution for Injection or Infusion - PA0281/225/001
  • Claforan Powder for Solution for Injection 500mg - PA0540/037/002
  • Genotropin MiniQuick 0.6mg Powder and Solvent for Solution for Injection - PA0822/128/005
  • Metaraminol 10mg/ml Solution for Injection/Infusion - PA22893/001/001
  • Perinal Cutaneous Spray - PA0278/017/001
  • Piriton 4mg Tablets - PA0678/080/001
  • Ultiva 5mg Powder for Concentrate for Solution for Infusion- PA1691/032/003


Please see the shortages section of the HPRA website for further information.

The HPRA sends weekly updates concerning medicinal product shortages. However, the above webpage will be updated as new information is provided to the HPRA.

« Back